ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

VCYT Veracyte Inc

22.54
0.78 (3.58%)
2024年6月22日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Veracyte Inc VCYT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.78 3.58% 22.54 07:55:24
始値 安値 高値 終値 前日終値
21.85 21.81 22.55 22.54 21.76
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1805:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1805:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1805:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1405:27EDGAR2Form 8-K - Current report
2024/6/1305:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/6/1205:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0505:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0505:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0505:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0505:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0505:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0405:05BWVeracyte Announces that New Afirma GRID Data Suggest..
2024/5/3105:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2905:26EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2305:05BWVeracyte Announces Multiple Afirma GRID Presentations at..
2024/5/1606:04BWVeracyte to Participate in Upcoming Investor Conferences
2024/5/0906:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0805:10EDGAR2Form 8-K - Current report
2024/5/0805:05BWVeracyte Announces First Quarter 2024 Financial Results
2024/5/0705:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
2024/4/2306:00BWVeracyte to Release First Quarter 2024 Financial Results on..
2024/4/2221:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
2024/4/1621:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
2024/3/0906:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:27EDGAR2Form 8-K - Current report
2024/3/0107:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
2024/3/0107:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0106:40EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/2922:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2807:55BWVeracyte’s Decipher Prostate Test Receives Highest..
2024/2/2306:12EDGAR2Form 8-K - Current report
2024/2/2306:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
2024/2/2207:00BWVeracyte to Participate in the Raymond James 45th Annual..
2024/2/1406:15EDGAR2Form 8-K - Current report
2024/2/0822:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
2024/2/0622:23EDGAR2Form 8-K - Current report
2024/2/0622:15BWVeracyte Completes Acquisition of C2i Genomics
2024/1/3006:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0822:12EDGAR2Form 8-K - Current report
2024/1/0822:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..

最近閲覧した銘柄